skip to main content

    Updated Visitor Guidelines

 

MENU

 

A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies

Information about this clinical trial has moved. You can now learn about it on this page.